Aker BioMarine rallies on rights deal to buy omega-3 firm
Aker BioMarine, the Norwegian fish food firm, announced plans for its second rights issue since May on Friday, a Nkr250m ($40.5m) deal to finance a joint-venture acquisition.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: